Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

被引：0
|
作者：
Hannaleena Eerola
Päivi Heikkilä
Anitta Tamminen
Kristiina Aittomäki
Carl Blomqvist
Heli Nevanlinna
机构：
[1] Helsinki University Central Hospital,Department of Oncology
[2] Helsinki University Central Hospital,Department of Obstetrics and Gynecology
[3] Helsinki University Central Hospital,Department of Pathology
[4] Helsinki University Central Hospital,Department of Clinical Genetics
来源：
Breast Cancer Research | / 7卷
关键词：
Progesterone Receptor; BRCA2 Mutation; BRCA1 Carrier; Sporadic Breast Cancer; Breast Cancer Family;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients
    Sokolenko, Anna P.
    Preobrazhenskaya, Elena V.
    Aleksakhina, Svetlana N.
    Iyevleva, Aglaya G.
    Mitiushkina, Natalia V.
    Zaitseva, Olga A.
    Yatsuk, Olga S.
    Tiurin, Vladislav I.
    Strelkova, Tatiana N.
    Togo, Alexandr V.
    Imyanitov, Evgeny N.
    CANCER LETTERS, 2015, 359 (02) : 259 - 261
  • [22] Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer
    Ji Soo Park
    Seung-Tae Lee
    Eun Ji Nam
    Jung Woo Han
    Jung-Yun Lee
    Jieun Kim
    Tae Il Kim
    Hyung Seok Park
    BMC Cancer, 18
  • [23] Mutation analysis of the BRCA1 gene in breast cancer families
    Pohlreich, P
    Stribrna, J
    Zikan, M
    Kremen, J
    Kostirova, M
    Konopasek, B
    CHEMICAL PAPERS, 1998, 52 : 288 - 288
  • [24] BRCA1 mutation detection in Scottish breast cancer families
    Boyd, M
    Renwick, A
    McFarlane, R
    Black, DM
    BRITISH JOURNAL OF CANCER, 1996, 74 : 2 - 2
  • [25] OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer
    Masanobu Takahashi
    Natsuko Chiba
    Hideki Shimodaira
    Yuki Yoshino
    Takahiro Mori
    Makiko Sumii
    Tadashi Nomizu
    Chikashi Ishioka
    Breast Cancer, 2017, 24 : 336 - 340
  • [26] OLA1 gene sequencing in patients with BRCA1/2 mutation-negative suspected hereditary breast and ovarian cancer
    Takahashi, Masanobu
    Chiba, Natsuko
    Shimodaira, Hideki
    Yoshino, Yuki
    Mori, Takahiro
    Sumii, Makiko
    Nomizu, Tadashi
    Ishioka, Chikashi
    BREAST CANCER, 2017, 24 (02) : 336 - 340
  • [27] Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
    S. L. Harvey
    R. L. Milne
    S. A. McLachlan
    M. L. Friedlander
    K. E. Birch
    P. Weideman
    D. Goldgar
    J. L. Hopper
    K. A. Phillips
    Breast Cancer Research and Treatment, 2011, 130 : 1057 - 1061
  • [28] Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families
    Harvey, S. L.
    Milne, R. L.
    McLachlan, S. A.
    Friedlander, M. L.
    Birch, K. E.
    Weideman, P.
    Goldgar, D.
    Hopper, J. L.
    Phillips, K. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 1057 - 1061
  • [29] Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Jan Lubinski
    Henry T. Lynch
    Susan L. Neuhausen
    Parviz Ghadirian
    Claudine Isaacs
    Barbara Weber
    Charmaine Kim-Sing
    William D. Foulkes
    Ruth Gershoni-Baruch
    Peter Ainsworth
    Eitan Friedman
    Mary Daly
    Judy E. Garber
    Beth Karlan
    Olufunmilayo I. Olopade
    Nadine Tung
    Howard M. Saal
    Andrea Eisen
    Michael Osborne
    Hakan Olsson
    Dawna Gilchrist
    Ping Sun
    Steven A. Narod
    Cancer Causes & Control, 2005, 16 : 667 - 674
  • [30] Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, J
    Lubinski, J
    Lynch, HT
    Neuhausen, SL
    Ghadirian, P
    Isaacs, C
    Weber, B
    Kim-Sing, C
    Foulkes, WD
    Gershoni-Baruch, R
    Ainsworth, P
    Friedman, E
    Daly, M
    Garber, JE
    Karlan, B
    Olopade, OI
    Tung, N
    Saal, HM
    Eisen, A
    Osborne, M
    Olsson, H
    Gilchrist, D
    Sun, P
    Narod, SA
    CANCER CAUSES & CONTROL, 2005, 16 (06) : 667 - 674
12345